VARIANT SARS-CoV-2 PROTEINS AND USES THEREOF
The present disclosure relates to variants of SARS-CoV-2 nucleocapsid protein, spike protein, and spike protein receptor binding domain (RBD), as well as nucleic acids encoding such variants and methods of use thereof. Such variants are useful in diagnostic test kits and vaccines for SARS-CoV-2.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to variants of SARS-CoV-2 nucleocapsid protein, spike protein, and spike protein receptor binding domain (RBD), as well as nucleic acids encoding such variants and methods of use thereof. Such variants are useful in diagnostic test kits and vaccines for SARS-CoV-2. |
---|---|
Bibliography: | Application Number: US202117923327 |